Home >
Medicine Info >
Mimcipar 30 Tablet
Loading interface...

Mimcipar 30 Tablet

Manufactured byPANACEA BIOTEC LTD
ContainsCinacalcet
Description
Mimcipar 30 Tablet is a calcimimetic agent, a medicine that mimics or copies the actions of calcium on the tissues. It is used to treat secondary hyperparathyroidism (overactivity of the parathyroid glands causing an increased amount of parathyroid hormone in the blood) if you have serious kidney conditions and are being treated with dialysis (a procedure to remove waste products and excess fluid from the blood). It is also used to treat hypercalcaemia (high blood calcium levels) associated with parathyroid cancer (cancer of the glands in the neck). Mimcipar 30 Tablet can cause side effects like back pain, headache, nausea, vomiting, diarrhoea, loss of appetite, etc. Consult your doctor if these side effects persist or worsen. Avoid driving vehicles and operating machines after taking this medicine, as this medicine can make you feel dizzy. Mimcipar 30 Tablet should be taken with food or shortly after a meal. Your doctor will determine the dose and duration of treatment based on your condition. Avoid taking more or less than the prescribed dose. Do not stop taking this medication without consulting your doctor, as it may further worsen your condition. Mimcipar 30 Tablet is not recommended if you are allergic to it. Inform your doctor about your current medications and pre-existing medical conditions before taking this medicine to make sure it is safe for you. If you are pregnant or breastfeeding, consult your doctor before taking this medicine.
QUICK LINKS:
Side effectsConcernsUsage

Side effects

Major & minor side effects for Mimcipar 30 Tablet

  • Headache
  • Difficult or painful urination
  • Fever or chills
  • Lower back or side pain
  • Muscle spasm
  • Dizziness
  • Nausea or Vomiting
  • Diarrhoea
  • Blurred vision
  • Loss of appetite

Uses of Mimcipar 30 Tablet

What is it prescribed for?

  • Secondary Hyperparathyroidism
  • Hypercalcemia of malignancy
  • Primary Hyperparathyroidism
Read More
Concerns

Commonly asked questions

  • How long does it take for this medicine to take effect?
    The amount of time required for Mimcipar 30 Tablet to show its action is not clinically established.
  • How long do the effects of this medicine last?
    The time duration for which Mimcipar 30 Tablet remains active in the body is not clinically established.
  • Is it safe to consume alcohol while taking this medicine?
    Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.
  • Is this a habit forming medicine?
    No habit-forming tendencies were reported for Mimcipar 30 Tablet.
  • Can this medicine be taken during pregnancy?
    Due to the lack of safety data, Mimcipar 30 Tablet is not recommended for use during pregnancy unless necessary. Consult your doctor if you are pregnant.
  • Can this medicine be taken while breast-feeding?
    Due to the lack of safety information, Mimcipar 30 Tablet is not recommended for use while breastfeeding.

Allergy

Mimcipar 30 Tablet is not recommended if you are allergic to it. Seek immediate medical attention if you notice any symptoms such as skin rash, itching/swelling (especially of the face/tongue/throat), severe dizziness, breathing difficulty, etc.

Hypocalcemia

Mimcipar 30 Tablet is not recommended for use if you have hypocalcaemia (low blood calcium levels) as it may further worsen your condition.
Warnings for special population

Pregnancy

Due to the lack of safety data, Mimcipar 30 Tablet is not recommended for use during pregnancy unless necessary. Consult your doctor if you are pregnant.

Breast-feeding

Due to the lack of safety information, Mimcipar 30 Tablet is not recommended for use while breastfeeding.
General warnings

Chronic kidney disease without being treated with dialysis

Mimcipar 30 Tablet is not recommended for use in people having chronic kidney conditions who are not being treated with dialysis due to the increased risk of hypocalcaemia (low blood calcium levels).

Gastrointestinal bleeding

Mimcipar 30 Tablet should be used with caution if you have stomach and intestinal conditions causing gastrointestinal bleeding as it may further worsen your condition.

Adynamic bone disease

Adynamic bone disease is a bone disorder associated with kidney conditions. It causes alteration in bone morphology and bone formation. This may increase the risk of fractures and other bone-related problems. Mimcipar 30 Tablet should be used with extreme caution as the suppression of parathyroid hormone (PTH) levels beyond a certain limit (100 pg/ml) may increase the risk of adynamic bone disease. Your doctor will monitor your PTH levels closely during treatment with this medicine and adjust your dose if necessary.

Low blood calcium levels

Mimcipar 30 Tablet may cause an increased risk of low blood calcium levels. Hence your doctor will closely monitor your blood calcium levels while you are taking this medicine.

Use in children

Mimcipar 30 Tablet is not recommended for use in children less than 18 years of age as the safety and efficacy data are not clinically established.

Driving or operating machines

Mimcipar 30 Tablet can cause dizziness. Hence avoid performing activities that require mental alertness such as driving vehicles or operating machines.

Missed Dose

Take the missed dose of Mimcipar 30 Tablet as soon as you remember. If it is time for your next dose, skip the missed dose. Do not double your dose to make up for the missed dose.

Overdose

Never take more than the prescribed dose. Seek emergency medical treatment in case of an overdose of Mimcipar 30 Tablet.
All drugs interact differently for person to person. You should check all the possible interactions with your doctor before starting any medicine.
Interaction with Alcohol

Description

Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.

Instructions

Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.
Interaction with Medicine

Amitriptyline

Pimozide

Carvedilol

Clarithromycin

Tamoxifen

Thioridazine

Fluvoxamine

Disease interactions

Seizures

Mimcipar 30 Tablet should be used with extreme caution if you have a history of seizures (sudden, abnormal electrical disturbances in the brain causing uncontrolled jerking of the body) as it may trigger or aggravate the condition.

Hypotension

Mimcipar 30 Tablet may alter the blood pressure and should be used with caution if you have hypotension (low blood pressure). Monitor your blood pressure frequently while you are taking this medicine.
Food interactions
Information not available.
Lab interactions
Information not available.
This is not an exhaustive list of possible drug interactions. You should consult your doctor about all the possible interactions of the drugs you’re taking.
Take Mimcipar 30 Tablet with food. Do not break, chew, or crush the tablet in your mouth. Swallow as a whole with plenty of water. Follow all the instructions given on the prescription label/packing insert. Do not take more or less than the recommended dose of Mimcipar 30 Tablet. Take this medicine for the recommended duration. Do not discontinue this medication abruptly without consulting your doctor. Take Mimcipar 30 Tablet at the same time every day for the ease of remembering. Consult your doctor immediately if you experience any side effects that persist or worsen. Keep Mimcipar 30 Tablet away from the reach of children and pets. Ensure that the unused or expired medicine is disposed of properly. Your doctor may suggest frequent blood tests to monitor your blood calcium levels during treatment with this medicine. Other vitals like blood pressure may also be evaluated from time to time.
Miscelleneous

To be taken with food

To be taken as instructed by doctor

Effect on sleep is not established

How it works
Mimcipar 30 Tablet works by stopping the excess production of the parathyroid hormone by the parathyroid glands, which also helps control calcium and phosphorous levels in the body.
Legal Status

Approved

Approved

Approved

Approved

Classification

Category

Calcimimetics

Schedule

Schedule H

Drugs, H., 2022. Cinacalcet: MedlinePlus Drug Information. [online] Medlineplus.gov. Available at: [Accessed 6 April 2022].

https://medlineplus.gov/druginfo/meds/a605004.html

Medicines.org.uk. 2022. Mimpara 30 mg Film-coated Tablets - Summary of Product Characteristics (SmPC) - (emc). [online] Available at: [Accessed 6 April 2022].

https://www.medicines.org.uk/emc/product/5599/smpc#

Pi.amgen.com. 2022. [online] Available at: [Accessed 6 April 2022].

https://pi.amgen.com/~/media/amgen/repositorysites/pi-amgen-com/sensipar/sensipar_pi_hcp_english.ashx

Ebs.tga.gov.au. 2022. TGA eBS - Product and Consumer Medicine Information Licence. [online] Available at: [Accessed 6 April 2022].

https://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent&id=CP-2010-PI-05724-3&d=2018072716114622483

Accessdata.fda.gov. 2022. [online] Available at: [Accessed 6 April 2022].

https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/021688s017lbl.pdf

Dailymed.nlm.nih.gov. 2022. DailyMed - SENSIPAR- cinacalcet hydrochloride tablet, coated. [online] Available at: [Accessed 6 April 2022].

https://www.dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=45028573-13c4-4c8b-ae62-6c75bba97c81
Loading related questions...
Something doesn’t feel right?
Report an error

Information on this page was last updated on 27 Jun 2022

Disclaimer

We’ve made all possible efforts to ensure that the information provided here is accurate, up-to-date and complete, however, it should not be treated as a substitute for professional medical advice, diagnosis or treatment. Practo only provides reference source for common information on medicines and does not guarantee its accuracy or exhaustiveness. The absence of a warning for any drug or combination thereof, should not be assumed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Practo does not assume any responsibility for any aspect of healthcare administered with the aid of information provided above. If you have any doubts about your medication then we strongly recommend that you consult with your doctor, nurse or healthcare provider. See detailed T&C here.